PLx Pharma
PLx Pharma Inc. — Creator of PL2200 Aspirin and PL1100 Ibuprofen.
Launch date
Employees
Market cap
€2.3m
Enterprise valuation
(€7m) (Public information from Apr 2023)
Share price
$0.004 PLXP
Houston Texas (HQ)
Financials
Estimates*
| USD | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Revenues | - | - | - | - | 9.0m | 32.0m |
| % growth | - | - | - | - | - | 256 % |
| EBITDA | - | (11.0m) | (15.0m) | (26.0m) | - | - |
| Profit | (15.0m) | - | (34.0m) | (16.0m) | (48.0m) | (41.0m) |
| % profit margin | - | - | - | - | (533 %) | (128 %) |
| EV / revenue | - | - | - | - | 16.2x | 4.6x |
| EV / EBITDA | - | -1.2x | -2.7x | -2.9x | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | N/A | IPO | |
| N/A | $1.3m | Debt | |
N/A | Debt | ||
| N/A | $63.0m | Post IPO Equity | |
| N/A | N/A | Bankruptcy | |
| Total Funding | €23.0m | ||
Related Content
Recent News about PLx Pharma
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by PLx Pharma
Edit
ACQUISITION by PLx Pharma Dec 2016